Posted in | News

Powder Flow Seminar Series continues in Pennsylvania, USA

Powder flow specialists, Freeman Technology will continue their ‘Powder Flow Seminar’ series on October 3rd 2018 at LPW Technology’s facility in Imperial, PA. The free one-day event will hear leaders in the field discuss the applications of powder rheology in Additive Manufacturing.

The seminar will include presentations from John Yin, Product Manager at Freeman Technology, who will provide an introduction to understanding powder flow and powder behavior, and Nate Kistler, Application Engineer at LPW Technology USA, who will discuss increasing the life span of IN718 in powder bed fusion additive manufacturing.

Delegates will also hear from guest speakers, Andrew Klein, Manager of Material & Process Development at ExOne, who will review binder jet 3D printing; and Zack Snow from Pennsylvania State University, who will look at the development of powder spreadability metrics and feedstock requirements for powder bed fusion additive manufacturing.

There will also be an opportunity for delegates to see a demonstration of Freeman Technology’s FT4 Powder Rheometer® and a tour of LPW’s facility.

To access the full agenda please visit the Freeman Technology website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Freeman Technology. (2018, August 22). Powder Flow Seminar Series continues in Pennsylvania, USA. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=49516.

  • MLA

    Freeman Technology. "Powder Flow Seminar Series continues in Pennsylvania, USA". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=49516>.

  • Chicago

    Freeman Technology. "Powder Flow Seminar Series continues in Pennsylvania, USA". AZoM. https://www.azom.com/news.aspx?newsID=49516. (accessed November 23, 2024).

  • Harvard

    Freeman Technology. 2018. Powder Flow Seminar Series continues in Pennsylvania, USA. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=49516.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.